(Q30380898)

21 June 2017

1 reference

title

Recombinant vectors as influenza vaccines. (English)

1 reference

21 June 2017

2

Peter Palese

1 reference

21 June 2017

author name string

Sarah A Kopecky-Bromberg

series ordinal

1

1 reference

21 June 2017

publication date

1 January 2009

1 reference

Current Topics in Microbiology and Immunology

21 June 2017

published in

1 reference

21 June 2017

volume

333

1 reference

21 June 2017

page(s)

243-267

1 reference

Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles

21 June 2017

cites work

1 reference

12 December 2020

Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents

1 reference

12 December 2020

Recombinant poxviruses as mucosal vaccine vectors

1 reference

12 December 2020

Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope

1 reference

12 December 2020

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis

1 reference

12 December 2020

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus

1 reference

12 December 2020

Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme

1 reference

12 December 2020

Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens

1 reference

12 December 2020

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

1 reference

12 December 2020

Prevention of adenoviral acute respiratory disease in Army recruits: cost-effectiveness of a military vaccination policy

1 reference

12 December 2020

A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

1 reference

12 December 2020

Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity

1 reference

12 December 2020

Adenovirus infections in the immunocompromised host

1 reference

12 December 2020

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

1 reference

12 December 2020

Recombinant Newcastle disease virus as a vaccine vector.

1 reference

12 December 2020

Recombinant viruses as vaccines against viral diseases

1 reference

12 December 2020

Replication-defective bovine adenovirus type 3 as an expression vector

1 reference

12 December 2020

Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp

1 reference

12 December 2020

Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2)

1 reference

12 December 2020

A phase 1 clinical study of intravenous administration of PV701, an oncolytic virus, using two-step desensitization

1 reference

12 December 2020

Contact transmission of vesicular stomatitis virus New Jersey in pigs

1 reference

12 December 2020

Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses

1 reference

12 December 2020

Intracellular bacteria as targets and carriers for vaccination

1 reference

12 December 2020

An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice

1 reference

12 December 2020

A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge.

1 reference

12 December 2020

Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B.

1 reference

12 December 2020

Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo

1 reference

12 December 2020

Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.

1 reference

12 December 2020

Expression of transgenes from newcastle disease virus with a segmented genome

1 reference

12 December 2020

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach

1 reference

12 December 2020

Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza

1 reference

12 December 2020

Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women

1 reference

12 December 2020

Influenza virus vectors

1 reference

12 December 2020

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

1 reference

12 December 2020

Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors.

1 reference

12 December 2020

Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo

1 reference

12 December 2020

Gene therapy death prompts review of adenovirus vector

1 reference

12 December 2020

Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease.

1 reference

12 December 2020

Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy

1 reference

12 December 2020

The quest for human cancer viruses.

1 reference

12 December 2020

Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus

1 reference

12 December 2020

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses

1 reference

12 December 2020

Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice

1 reference

12 December 2020

The Hitchner B1 strain of Newcastle disease virus induces high levels of IgA, IgG and IgM in newly hatched chicks

1 reference

12 December 2020

Viral vectors for malaria vaccine development

1 reference

12 December 2020

Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease

1 reference

12 December 2020

Venezuelan equine encephalitis

1 reference

12 December 2020

New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.

1 reference

12 December 2020

An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge

1 reference

12 December 2020

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

1 reference

12 December 2020

Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes

1 reference

12 December 2020

Replication-defective vector based on a chimpanzee adenovirus

1 reference

12 December 2020

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates

1 reference

12 December 2020

Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats

1 reference

12 December 2020

Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines

1 reference

12 December 2020

Bacteria as DNA vaccine carriers for genetic immunization

1 reference

12 December 2020

Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants

1 reference

12 December 2020

Emergence and re-emergence of vesicular stomatitis in the United States

1 reference

12 December 2020

Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission

1 reference

12 December 2020

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

1 reference

12 December 2020

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector

1 reference

12 December 2020

Derivation and characterization of a live attenuated equine influenza vaccine virus

1 reference

12 December 2020

Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.

1 reference

12 December 2020

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

1 reference

12 December 2020

A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector

1 reference

12 December 2020

Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1.

1 reference

12 December 2020

Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants

1 reference

12 December 2020

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

1 reference

12 December 2020

1 reference

12 December 2020

Rational design of gene-based vaccines

1 reference

12 December 2020

Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

1 reference

12 December 2020

Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes

1 reference

12 December 2020

Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination

1 reference

12 December 2020

Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity

1 reference

12 December 2020

Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection

1 reference

12 December 2020

Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.

1 reference

12 December 2020

Rational design of Salmonella recombinant vaccines

1 reference

12 December 2020

High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.

1 reference

12 December 2020

Vesicular stomatitis virus as an oncolytic vector

1 reference

12 December 2020

Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles

1 reference

12 December 2020

Recombinant vesicular stomatitis viruses encoding simian immunodeficiency virus receptors target infected cells and control infection

1 reference

12 December 2020

Influenza virus NS vectors expressing the mycobacterium tuberculosis ESAT-6 protein induce CD4+ Th1 immune response and protect animals against tuberculosis challenge.

1 reference

12 December 2020

Recombinant Newcastle disease virus as a vaccine vector

1 reference

12 December 2020

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

12 December 2020

Listeria monocytogenes as novel carrier system for the development of live vaccines

1 reference

12 December 2020

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector

1 reference

12 December 2020

Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate

1 reference

12 December 2020

Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants

1 reference

12 December 2020

Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus

1 reference

12 December 2020

Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1

1 reference

12 December 2020

Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza virus: detection of mutations in all genes of the A/Ann Arbor/6/60 (H2N2) mutant vaccine donor strain

1 reference

12 December 2020

Generation and characterization of a recombinant vesicular stomatitis virus expressing the glycoprotein of Borna disease virus

1 reference

12 December 2020

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy

1 reference

12 December 2020

Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates

1 reference

12 December 2020

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine

1 reference

12 December 2020

A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus

1 reference

12 December 2020

Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge

1 reference

12 December 2020

Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors

1 reference

12 December 2020

Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin

1 reference

12 December 2020

Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial

1 reference

12 December 2020

Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.

1 reference

12 December 2020

Development of novel influenza virus vaccines and vectors

1 reference

12 December 2020

Attenuated measles virus as a vaccine vector

1 reference

12 December 2020

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles

1 reference

12 December 2020

Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine

1 reference

12 December 2020

A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.

1 reference

12 December 2020

Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma

1 reference

12 December 2020

Is there a role for plant-made vaccines in the prevention of HIV/AIDS?

1 reference

12 December 2020

Redesign and genetic dissection of the rhabdoviruses

1 reference

12 December 2020

Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol

1 reference

12 December 2020

Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits

1 reference

12 December 2020

Adenoviruses as vectors for delivering vaccines to mucosal surfaces

1 reference

12 December 2020

Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector.

1 reference

12 December 2020

Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1

1 reference

12 December 2020

Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons

1 reference

12 December 2020

Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.

1 reference

12 December 2020

Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection

1 reference

12 December 2020

One step forward, two steps back--will there ever be an AIDS vaccine?

1 reference

12 December 2020

Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge

1 reference

12 December 2020

Distribution of vesicular stomatitis virus proteins in the brains of BALB/c mice following intranasal inoculation: an immunohistochemical analysis

1 reference

12 December 2020

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV)

1 reference

12 December 2020

Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants.

1 reference

12 December 2020

Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development

1 reference

12 December 2020

Development and use of fowlpox vectored vaccines for avian influenza

1 reference

12 December 2020

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

12 December 2020

Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

1 reference

12 December 2020

Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis

1 reference

12 December 2020

The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system

1 reference

12 December 2020

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein

1 reference

12 December 2020

Alphavirus replicon particles as candidate HIV vaccines

1 reference

12 December 2020

Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.

1 reference

12 December 2020

Role of fusion protein cleavage site in the virulence of Newcastle disease virus

1 reference

12 December 2020

Virus treatment questioned after gene therapy death

1 reference

12 December 2020

10.1007/978-3-540-92165-3_13

Identifiers

DOI

1 reference

21 June 2017

1 reference